By admin, on August 29th, 2010%
Cheap Clinical Periodontology and Implant Dentistry Discount Review Shop
This edition of the classic textbook is a great source of all relevant aspects of periodontal units and a contemporary of oral implantology. The author, Jan Lindhe, is a noted researcher, clinican, and has several outstanding publications that brought him there, published in the forefront on this issue. The advantage of this book is a combination of Periodontology on other aspects of dentistry: implentology and prostheses, occlusion, orthodontics and aesthetics. BeyondThis book provides the scientific base of clinical guidelines. Another issue that concerns this book is the relationship between periodontal and systemic health of the individual – which is an average potential audience for the next issue.
Available at Amazon
Cheap “Clinical Periodontology and Implant Dentistry” Discount Review Shop
Continue reading Clinical Periodontology and Implant Dentistry for £116.08
By admin, on August 28th, 2010%
Cheap Clinical Anaesthesia (Lecture Notes) Discount Review Shop
Available at Amazon
Cheap “Clinical Anaesthesia (Lecture Notes)” Discount Review Shop
Continue reading Clinical Anaesthesia (Lecture Notes) for £16.49
By admin, on June 6th, 2010%
Relevare Pharmaceuticals Presents Latest Clinical Trial Data On CNSB015 At Third International Congress On Neuropathic …
Relevare Pharmaceuticals Ltd. will present its recent Phase IIa proof-of-concept clinical trial data and extension study results for CNSB015 (flupirtine), its lead repositioned compound, at the Third International Congress on Neuropathic Pain on May 27 – 30 in Athens, Greece. Dr…
Read . . . → Read More: Relevare Pharmaceuticals Presents Latest Clinical Trial Data On CNSB015 At Third International Congress On Neuropathic . . .
By admin, on May 1st, 2010%
BUSINESS WIRE: Ipsens Partner Roche Announces That Taspoglutide Meets Its Primary Endpoint in a Key Phase III Clinical …
MITTEILUNG UEBERMITTELT VON BUSINESS WIRE. FUER DEN INHALT IST ALLEIN DAS BERICHTENDE UNTERNEHMEN VERANTWORTLICH.
Read more . . . → Read More: Business Wire: Roche Announces Partner Ipsens Taspoglutide meet its primary endpoint in a phase III of clinical importance. . .
By admin, on April 20th, 2010%
Phase II clinical study examining CTT’s Calmare pain therapy medical device completed
Competitive Technologies, Inc. announced today that Thomas J. Smith, MD FACP, and co-investigator Patrick J. Coyne, MSN, APRN, FAAN, of Virginia Commonwealth University’s Massey Cancer Center have completed their open Phase II clinical study examining CTT’s Calmare pain therapy medical device’s efficacy treating patients suffering . . . → Read More: Phase II clinical study examining CTT’s Calmare pain therapy medical device completed
By admin, on March 27th, 2010%
(AFX UK Focus) 2010-03-24 09:02 UPDATE 1-Vernalis dives as pain drug fails clinical test
LONDON, March 24 (Reuters) – An experimental drug for diabetes-related neuropathic pain from Vernalis failed to show benefits in a clinical trial, sending shares in the British biotech group plunging on Wednesday. Vernalis said it did not plan to conduct further studies with . . . → Read More: (AFX UK Focus) 2010/03/24 09:02 UPDATE 1-diving vernalis pain drug fails clinical trial
By admin, on March 13th, 2010%
Product description of the last 2 years have seen enormous progress in understanding the basic biological, genetic and clinical characteristics of peripheral nerve diseases. This remains a difficult area for professionals anymore. This text combines a thorough review of the literature with clinical experience to present a comprehensive neurological but concise and readable for knowledge, assessment . . . → Read More: Peripheral neuropathies in Clinical Practice
By admin, on February 2nd, 2010%
Product Description Harvard Medical School, Boston, MA. Comprehensive volume concentrating on clinical aspects of diabetic neuropathy and its current management and causes. Special emphasis is given to current treatments and those expected to become available in the near future. For physicians. DNLM: Diabetic Neuropathies–therapy.
Clinical Management of Diabetic . . . → Read More: Clinical Management of Diabetic Neuropathy
